Immunotech Laboratories, Inc. (IMMB)

Immunotech Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2009
Period Ending	Dec 31, 2009
Selling, General & Admin	0.65
Research & Development	0.29
Operating Expenses	0.96
Operating Income	-0.96
Interest Expense	-0.02
Pretax Income	-0.98
Net Income	-0.98
Net Income to Common	-0.98
Shares Outstanding (Basic)	61
Shares Outstanding (Diluted)	61
EPS (Basic)	-0.02
EPS (Diluted)	-0.02
EBITDA	-0.94
D&A For EBITDA	0.01
EBIT	-0.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.